l9n/ Oregon

2017 Regular Session

House Bill 2116

Creates Help In Cutting Costs for Unusual Pharmaceuticals program in Oregon Health Authority to reimburse high costs incurred by persons in this state to purchase certain pharmaceutical products.

Did not become law. It stopped in the House of Representatives's Health Care Committee on July 7, 2017. The 2017 session has ended.

What it does

The synopsis the Legislative Assembly published with the bill.

Creates Help In Cutting Costs for Unusual Pharmaceuticals program in Oregon Health Authority to reimburse high costs incurred by persons in this state to purchase certain pharmaceutical products. Requires Department of Revenue to transfer specified amount of corporate excise taxes paid on Oregon sales of pharmaceutical products by pharmaceutical manufacturers doing business in Oregon to pay for administration of program.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the House of Representatives

Its course

January 9 to July 7, 2017, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action4 actions on 4 days

In the House of RepresentativesJan 9 to Jul 7 · stopped179 days

Waiting for a committeeJan 9 to Jan 178 days

Health CareJan 17 to Jul 7 · stopped171 days

Text

Each version as the Legislative Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the Legislative Assembly published it is below.

In the House of Representatives Jan 9 – Jul 7

  1. Jan 9Introduced
  2. Jan 17Sent to Health Care
  3. Mar 3Heard in Health Care
  4. Jul 7Died when the session ended
All 4 actions, as published
  1. Jan 9First reading. Referred to Speaker's desk.House of Representatives
  2. Jan 17Referred to Health Care with subsequent referral to Ways and Means.House of Representatives
  3. Mar 3Public Hearing held.House of Representatives
  4. Jul 7In committee upon adjournment.House of Representatives